# Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-efficacy-and-safety-of-rituximab-in-igg4-related-disease-data-from-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mikaël Ebbo,A. Grados,M. Samson,Matthieu Groh,Anderson Loundou,Aude Rigolet,Benjamin Terrier,Constance Guillaud,Clarisse Carra‐Dallière,F. Renou,Agnieszka Pozdzik,Pierre Labauge,S. Palat,Jean‐Marie Berthelot,Jean‐Loup Pennaforte,Alain Wynckel,Céline Lebas,N. Le Gouellec,T. Quéméneur,Karine Dahan,Franck Carbonnel,Gaëlle Leroux,Antoinette Perlat,Alexis Mathian,P. Cacoub,É. Hachulla,N. Costedoat‐Chalumeau,Jean‐Robert Harlé,N. Schleinitz |
| Citations | 251 |
| DOI | 10.1371/journal.pone.0183844 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183844&type=printable |
| OpenAlex ID | https://openalex.org/W2755478460 |
| PMID | 28915275 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Agnieszka Pozdzik](https://scholariq.org/researchers/agnieszka-pozdzik/)

## Paper journal

- [PLoS ONE](https://scholariq.org/journals/plos-one/)

## Paper primary topic

- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)

## Paper topics

- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Nasolacrimal Duct Obstruction Treatments](https://scholariq.org/topics/nasolacrimal-duct-obstruction-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.